Target intelligence / Profile preview

EBAG9 pseudogene 1 (EBAG9P1)

Target
EBAG9P1
Molecular classification
Other (Pseudogene)
01

Overview

The EBAG9 pseudogene 1 (EBAG9P1) is a non-functional genomic sequence related to the EBAG9 gene, which encodes a membrane-associated antigen known for being estrogen-inducible and involved in the regulation of exocytosis, immune response modulation, and cancer pathophysiology. As a pseudogene, EBAG9P1 does not code for a functional protein and is not itself considered a therapeutic target or of known biological or pathological significance[7].

Other names
estrogen receptor binding site associated, antigen, 9 pseudogene 1EBAG9P1

Beyond the preview

Go deeper on EBAG9 pseudogene 1 (EBAG9P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on EBAG9 pseudogene 1 (EBAG9P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call